MedPath

Fexofenadine HCL

Fexofenadine Hydrochloride Tablets USP, 180 mg

Approved
Approval ID

353323b7-67ce-7ce6-e063-6394a90a77d4

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 15, 2025

Manufacturers
FDA

Walmart Inc.

DUNS: 051957769

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fexofenadine HCL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code79903-358
Application NumberANDA204097
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fexofenadine HCL
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (14)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL 6000Inactive
Code: 30IQX730WE
Classification: IACT
FEXOFENADINE HYDROCHLORIDEActive
Quantity: 180 mg in 1 1
Code: 2S068B75ZU
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 3/6/2019

PRINCIPAL DISPLAY PANEL

Fexofenadine Hydrochloride Tablets, USP 180 mg 45ct CTN

![PRINCIPAL DISPLAY PANEL](/dailymed/image.cfm?name=45ct-180mg- Equate+Fexofenadine-Carton.jpg&id=876619)

Fexofenadine Hydrochloride Tablets, USP 180 mg 45ct LBL

![PRINCIPAL DISPLAY PANEL](/dailymed/image.cfm?name=45ct-180mg- Equate+Fexofenadine-LBL.jpg&id=876619)

Fexofenadine Hydrochloride Tablets, USP 180 mg 90ct LBL

![PRINCIPAL DISPLAY PANEL](/dailymed/image.cfm?name=90ct-180mg- Equate+Fexofenadine-LBL.jpg&id=876619)

Fexofenadine Hydrochloride Tablets, USP 180 mg 180ct CTN

![PRINCIPAL DISPLAY PANEL](/dailymed/image.cfm?name=180ct-180mg- Equate+Fexofenadine-Carton.jpg&id=876619)

Fexofenadine Hydrochloride Tablets, USP 180 mg 300ct LBL

![PRINCIPAL DISPLAY PANEL](/dailymed/image.cfm?name=300ct-180mg- Equate+Fexofenadine-LBL.jpg&id=876619)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 3/6/2019

USE(S)

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

§ runny nose

§ sneezing

§ itchy, watery eyes

§ itching of the nose or throat

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 3/6/2019

KEEP OUT OF REACH OF CHILDREN

In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 3/6/2019

ACTIVE INGREDIENT(S), in each tablet

Fexofenadine hydrochloride USP, 180 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 3/6/2019

PURPOSE

Antihistamine

WARNINGS SECTION

LOINC: 34071-1Updated: 3/6/2019

WARNINGS

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 3/6/2019

DO NOT USE

if you have ever had an allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

LOINC: 50569-3Updated: 3/6/2019

ASK A DOCTOR BEFORE USE IF

you have kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 3/6/2019

WHEN USING THIS PRODUCT

§ do not take more than directed

§ do not take at the same time as aluminum or magnesium antacids

§ do not take with fruit juices (see Directions)

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 3/6/2019

STOP USE AND ASK A DOCTOR IF

an allergic reaction to this product occurs. Seek medical help right away.

**If pregnant or breast-feeding,**ask a health professional before use.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 3/6/2019

DIRECTIONS

60 mg

adults and children 12 years of age and over

take one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours

children under 12 years of age

do not use

adults 65 years of age and older

ask a doctor

consumers with kidney disease

ask a doctor

180 mg

adults and children 12 years of age and over

take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours

children under 12 years of age

do not use

adults 65 years of age and older

ask a doctor

consumers with kidney disease

ask a doctor

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 3/6/2019

OTHER INFORMATION

  •  Safety Sealed: do not use if carton is opened or if printed foil inner seal on the bottle is torn or missing.
  •  store between 20° and 25°C (68° and 77°F)
  •  protect from excessive moisture

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 3/6/2019

INACTIVE INGREDIENTS

Colloidal silicon dioxide, hypromellose, light liquid paraffin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, red iron oxide, sodium starch glycolate, talc, titanium dioxide and yellow iron oxide.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 3/6/2019

QUESTIONS OR COMMENTS

call toll-free weekdays 9 AM to 5 PM EST at1-888-588-1418

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fexofenadine HCL - FDA Drug Approval Details